Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2246]
News [4606]
Articles [190]
Editorials [8]
Conferences [133]
elearning [9]
Dabrafenib offers improved progression-free survival for melanoma patients
Dabrafenib offers improved progression-free survival for melanoma patients
Experimental combination for stomach and oesophageal cancer
Experimental combination for stomach and oesophageal cancer
ASCO 2012: New quality measures tested to encourage better taking of family histories and referral to genetic counseling
ASCO 2012: New quality measures tested to encourage better taking of family histories and referral to genetic...
ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours, particularly those with chromosomal mutations
ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours...
Knowing genetic makeup may not significantly improve disease risk prediction
Knowing genetic makeup may not significantly improve disease risk prediction
Discovery of mechanisms predicting response to new treatments in colon cancer
Discovery of mechanisms predicting response to new treatments in colon cancer
NICE green light for abiraterone for prostate cancer
NICE green light for abiraterone for prostate cancer
IMPAKT 2012: Breast cancer in young women: a distinct disease
IMPAKT 2012: Breast cancer in young women: a distinct disease
Researchers working at frontiers of melanoma research
Researchers working at frontiers of melanoma research
NICE rejects bevacizumab in combination with capecitabine for breast cancer
NICE rejects bevacizumab in combination with capecitabine for breast cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation